The biomarker CD3+/CD4-/CD8- identifies a unique subset of T lymphocytes that express the CD3 surface protein but lack both CD4 and CD8 co-receptors. These cells are often referred to as double-negative T cells (DN T cells) due to their absence of CD4 and CD8 expression. DN T cells represent a small fraction of the total T cell population in peripheral blood, typically accounting for less than 5% of T cells. Despite their rarity, these cells play important roles in immune regulation and have been implicated in various autoimmune diseases, transplant rejection, and cancer immunology. DN T cells can exhibit both immunosuppressive and pro-inflammatory functions, depending on the context. They are capable of producing cytokines and can have cytotoxic activity. The CD3+/CD4-/CD8- phenotype is typically assessed using flow cytometry, which allows for precise identification and quantification of this cell population. Alterations in the frequency or function of DN T cells may serve as indicators of immune dysregulation or specific disease states.f

What Does CD3+/CD4+, Abs Mean in a Blood Test? CD3+/CD4+, Abs stands for the absolute count of CD4+ T-helper cells within the total population of CD3+ T cells in the blood. This marker measures the exact number of helper T cells per microliter (μL) of blood, rather than just their percentage. It is a key indicator of immune system function, especially in the context of infections like HIV, immune deficiencies, and chronic inflammatory conditions. Understanding the Components CD3+ T cells: Represent all mature T lymphocytes, which are crucial for adaptive immunity. CD4+ T cells: A subset of CD3+ cells known as T-helper cells, which coordinate the immune response by signaling other immune cells (B cells, macrophages, cytotoxic T cells). "Abs" (Absolute): Refers to the actual number of CD3+/CD4+ cells per microliter of blood, typically expressed as cells/μL. Why Is CD3+/CD4+, Absolute Count Important? This marker is especially valuable for: Monitoring HIV infection and disease progression Diagnosing and tracking immunodeficiencies Evaluating immune recovery after bone marrow transplantation or chemotherapy Assessing immune activity in autoimmune or chronic inflammatory diseases Normal Range Typical reference range: 500 to 1,500 cells/μL Values may vary slightly between laboratories and based on age or clinical context. A CD4 count below 200 cells/μL is considered a critical threshold in HIV, often used to define AIDS. What Can a Low CD3+/CD4+, Abs Level Indicate? HIV/AIDS: One of the most common causes of decreased CD4+ counts. HIV specifically targets and destroys CD4+ T cells. Primary immunodeficiencies: Congenital disorders like SCID (Severe Combined Immunodeficiency) Bone marrow suppression: From chemotherapy, radiation, or certain infections Severe infections: Such as tuberculosis or cytomegalovirus (CMV) Autoimmune diseases: In some cases, CD4+ cells are depleted due to immune system dysregulation What Can a High CD3+/CD4+, Abs Level Indicate? Autoimmune diseases: Such as rheumatoid arthritis or lupus, where the immune system is overactive Allergic or atopic conditions: Asthma, eczema, or chronic allergies can stimulate CD4+ T cell production Recovery phase after infection or immunosuppression: CD4+ levels may temporarily rise as the immune system rebounds Certain leukemias or lymphoproliferative disorders: Rarely, elevated levels may reflect abnormal immune cell growth How Is This Test Used in Practice? CD3+/CD4+, Absolute Count is typically used alongside: CD8+ T cell counts CD4/CD8 ratio Total lymphocyte count HIV viral load (if applicable) Clinical symptoms and history It plays a central role in HIV care, helping guide decisions about when to start antiretroviral therapy or prophylactic antibiotics to prevent opportunistic infections. Summary The CD3+/CD4+, Absolute Count measures the number of helper T cells (CD4+) within your T-cell population, expressed as cells per microliter of blood. It is a key indicator of immune system health, especially in monitoring HIV, autoimmune conditions, immune recovery, or immune suppression. Abnormal values—either low or high—should be interpreted alongside other immune markers and your overall clinical context.

What Does CD3+/CD8+ % Mean in a Blood Test? CD3+/CD8+ % refers to the percentage of cytotoxic T cells (CD8+) among all T-lymphocytes (CD3+ cells) in your blood. This immune marker is measured using flow cytometry and is commonly included in T-cell subset panels to evaluate immune system status. Understanding the Components CD3+ T cells: Represent all mature T lymphocytes, which are essential for adaptive immunity. CD8+ T cells: A subset of CD3+ cells, often called cytotoxic T cells, that directly kill infected or abnormal cells (like virus-infected cells or cancer cells). CD3+/CD8+ %: Indicates the proportion of cytotoxic T cells among total T cells, helping assess immune activation, suppression, or imbalance. Why Is CD3+/CD8+ % Important? This marker is helpful in: Monitoring viral infections (especially HIV, where CD8+ levels often rise) Evaluating immune activation or suppression Tracking autoimmune and inflammatory conditions Assessing immune recovery after bone marrow transplant or chemotherapy Normal Range CD3+/CD8+ % Normal Range: Approximately 15% to 40% This range may vary by lab and patient population. What Can Cause Elevated CD3+/CD8+ % Levels? Viral Infections Acute or chronic viral infections—such as HIV, Epstein-Barr virus (EBV), cytomegalovirus (CMV), or influenza—can activate and expand CD8+ T cells, raising their percentage. HIV Infection CD8+ levels often increase in HIV, especially in the early stages, as the immune system tries to control the virus. Over time, a persistently high CD8+ % with a falling CD4+ % may indicate immune system stress or progression. Chronic Inflammation Conditions with long-standing immune activation (such as autoimmune diseases or certain cancers) can drive up CD8+ T-cell percentages. Immunosenescence (Age-Related Immune Changes) In older adults, CD8+ percentages may increase as part of a shift in T-cell composition related to immune aging. Certain Medications or Immune Therapies Immunomodulators or biologic therapies may alter T-cell distribution, increasing CD8+ populations. What Can Cause Low CD3+/CD8+ % Levels? Immunodeficiency syndromes Bone marrow suppression Severe infections Certain cancers (like lymphomas) Corticosteroids or chemotherapy How Is It Interpreted? CD3+/CD8+ % is most informative when considered alongside: CD4+ T cell percentage CD4/CD8 ratio Absolute CD8+ count Clinical history and symptoms Summary CD3+/CD8+ % measures the proportion of cytotoxic T cells among your total T cells and serves as a key indicator of immune system activity. Elevated levels are often seen in viral infections, HIV, and chronic inflammation, while low levels may reflect immune suppression or bone marrow dysfunction. This marker is best interpreted in context with other immune indicators and your overall clinical picture.

What Does CD3+/CD8+, Abs Mean in a Blood Test? CD3+/CD8+, Abs refers to the absolute count of cytotoxic T cells (CD8+) within the population of total T cells (CD3+) in your blood. This test measures the number of CD8+ T cells per microliter (μL) of blood and is a critical marker for evaluating immune function, especially in viral infections, immune disorders, and after immune-modulating treatments. Understanding the Components CD3+ T cells: Represent all mature T lymphocytes—key players in the adaptive immune system. CD8+ T cells: A subset of CD3+ T cells, known as cytotoxic T cells, that target and destroy virus-infected, cancerous, or otherwise abnormal cells. “Abs” (Absolute): Indicates the actual number of CD3+/CD8+ cells per microliter (μL) of blood, not just the percentage. Why Is the Absolute CD3+/CD8+ Count Important? The CD8+ absolute count provides important insight into: Immune activation during viral infections (e.g., HIV, CMV, EBV) T-cell immune surveillance and response Immune suppression or recovery following chemotherapy, transplant, or immunodeficiency Chronic inflammation or autoimmune disease activity It is frequently evaluated in combination with: CD4+ T-cell counts CD4/CD8 ratio Total lymphocyte count Normal Range Typical reference range: 150 to 1,000 cells/μL This may vary by lab, age, and health status. What Can a Low CD3+/CD8+, Abs Level Indicate? A decreased CD8+ count may be seen in: Advanced HIV/AIDS (as CD8+ cells become depleted over time) Primary or acquired immunodeficiencies Bone marrow suppression (due to chemotherapy, radiation, or certain infections) Severe viral infections that temporarily exhaust immune reserves Immunosuppressive therapy (e.g., corticosteroids, biologics) What Can a High CD3+/CD8+, Abs Level Indicate? An elevated CD8+ count may occur in: Viral infections (e.g., HIV, cytomegalovirus [CMV], Epstein-Barr virus [EBV], hepatitis viruses) – CD8+ T cells increase in response to infected cells. HIV infection – High CD8+ counts are common, especially in early stages, as the immune system tries to control the virus. Chronic inflammation or autoimmune conditions – Conditions like rheumatoid arthritis or lupus may trigger immune activation and increased CD8+ cell production. Certain lymphoproliferative disorders – Rarely, very high counts can reflect abnormal proliferation of T cells (e.g., some leukemias or lymphomas). Clinical Use The CD3+/CD8+, Abs value is especially useful in: Monitoring HIV progression (alongside CD4+ count and CD4/CD8 ratio) Assessing immune recovery after chemotherapy or transplant Evaluating the immune response to viral or chronic infections Diagnosing and tracking autoimmune or inflammatory diseases Summary CD3+/CD8+, Absolute Count reflects the number of cytotoxic T cells (CD8+) in your blood—an essential component of your immune defense against viruses and abnormal cells. Elevated levels often signal immune activation due to viral infection or inflammation, while low levels may point to immune suppression or deficiency. This marker is best interpreted in context with CD4+ counts, CD4/CD8 ratio, and your overall health history.

CD4/CD8 Ratio: What It Means The CD4/CD8 ratio is a critical marker of immune system health. It measures the balance between CD4+ T-helper cells and CD8+ cytotoxic T cells, two major subtypes of T lymphocytes. These cells play complementary roles in immune defense: CD4+ T-helper cells coordinate immune responses by activating other immune cells. CD8+ cytotoxic T cells directly attack infected or cancerous cells. The ratio is calculated by dividing the absolute count of CD4+ cells by that of CD8+ cells, and it provides insight into the state of immune regulation, activation, and balance. Normal CD4/CD8 Ratio A normal range is typically between 1.0 and 4.0, with some variation based on the lab and population. A balanced ratio indicates a healthy immune system capable of managing infections, inflammation, and other immune challenges effectively. Low CD4/CD8 Ratio A ratio below 1.0 indicates a relative decrease in CD4+ T cells, an increase in CD8+ T cells, or both. Implications of a Low Ratio Immunosuppression Common in conditions such as HIV/AIDS, where CD4+ T cells are specifically targeted and depleted. Can occur in other conditions that suppress CD4+ cells or increase CD8+ cell activation. Chronic Infections Persistent viral infections (e.g., cytomegalovirus (CMV) or hepatitis C) may cause CD8+ cell expansion, lowering the ratio. Autoimmune Diseases Some autoimmune conditions may lower CD4 counts or elevate CD8 activity, contributing to a skewed ratio. Cancer Certain cancers, particularly hematologic malignancies like lymphomas, can disrupt the CD4/CD8 balance. High CD4/CD8 Ratio A ratio above 4.0 typically reflects a relative increase in CD4+ T cells, a decrease in CD8+ T cells, or both. Implications of a High Ratio Immune Dysregulation A high ratio may indicate an inability to mount sufficient cytotoxic responses, making the body less effective at targeting infected or abnormal cells. Autoimmune Disorders Conditions like multiple sclerosis or systemic lupus erythematosus (SLE) may elevate CD4+ T-helper cells, contributing to the imbalance. Aging With age, CD8+ T cell levels may decline more significantly than CD4+ cells, leading to an elevated ratio. Clinical Uses of the CD4/CD8 Ratio Monitoring Immune Health Used in patients with HIV to assess disease progression and treatment efficacy. A declining ratio suggests worsening immune suppression. Evaluates immune recovery post-transplantation, chemotherapy, or immunosuppressive treatments. Identifying Immune Dysregulation Helps detect and monitor autoimmune diseases, chronic infections, or immune-related conditions like chronic fatigue syndrome (CFS) or post-viral syndromes. Assessing Aging and Immune Senescence Tracks immune system aging, as a declining ratio is often associated with reduced immune resilience in older adults. Interpreting CD4/CD8 Ratio Results in Context The ratio must be evaluated alongside absolute CD4 and CD8 counts, other immune markers, and clinical symptoms to provide a comprehensive picture of immune health. Trends over time are more informative than a single measurement. Steps to Address Abnormal CD4/CD8 Ratios Identify and Treat Underlying Causes Address chronic infections, inflammation, or autoimmune disorders that may contribute to the imbalance. Support Immune Health Ensure adequate nutrition, with a focus on immune-supportive nutrients (e.g., vitamin D, zinc, and antioxidants). Manage stress and improve sleep quality to regulate immune responses. Medical Interventions For conditions like HIV, antiretroviral therapy (ART) is crucial to restoring CD4+ counts and improving the ratio. Immune-modulating therapies may help in autoimmune conditions or post-infection recovery. Why the CD4/CD8 Ratio Matters The CD4/CD8 ratio is a key marker of immune balance and functionality. Deviations from the normal range can signal underlying immune dysfunction, chronic infections, or systemic health issues. Regular monitoring, combined with targeted interventions, can help restore immune health and optimize overall

What Does CD4/CD8 Ratio, CD3+ Mean in a Blood Test? The CD4/CD8 ratio (CD3+) is an important marker that reflects the balance between two major subsets of T lymphocytes—CD4+ helper T cells and CD8+ cytotoxic T cells—within the total T-cell population (CD3+). This ratio is a key indicator of immune system health, especially in conditions involving immune deficiency, chronic infections, inflammation, and immune reconstitution. Understanding the Components CD3+ T cells: Represent all mature T lymphocytes. Both CD4+ and CD8+ T cells fall under this category. CD4+ T cells: Also known as helper T cells, they coordinate immune responses by signaling other immune cells. CD8+ T cells: Also known as cytotoxic T cells, they destroy infected, damaged, or cancerous cells. CD4/CD8 Ratio (CD3+): The ratio of helper T cells to cytotoxic T cells within the CD3+ T-cell population. Why Is the CD4/CD8 Ratio Important? The CD4/CD8 ratio is used to assess: Immune competence (e.g., in HIV/AIDS) Immune system aging (immunosenescence) Chronic infections or inflammation Autoimmune diseases Immune reconstitution after bone marrow transplant or immunosuppressive therapy Normal Range Typical CD4/CD8 ratio: 1.0 to 3.5 A ratio >1.0 generally indicates a healthy immune balance. The ideal ratio can vary slightly depending on age, clinical context, and laboratory standards. What Can an Abnormal CD4/CD8 Ratio Indicate? Low CD4/CD8 Ratio (<1.0) HIV infection (hallmark of disease progression) Viral infections (e.g., CMV, EBV, chronic hepatitis) Immune suppression or deficiency Autoimmune diseases (e.g., lupus, rheumatoid arthritis) Aging-related immune decline (immunosenescence) High CD4/CD8 Ratio (>3.5) Autoimmune conditions (e.g., multiple sclerosis, sarcoidosis) Post-infection or immune recovery phase Bone marrow or thymic hyperactivity Some allergic or hypersensitivity reactions What Does "CD4/CD8 Ratio, CD3+" Specifically Emphasize? The “CD3+” notation clarifies that the ratio is calculated using CD4+ and CD8+ T cells that are CD3-positive—in other words, mature T lymphocytes. This is a standard approach in flow cytometry and ensures that only functionally relevant T cells are counted. What Should You Do If Your CD4/CD8 Ratio Is Abnormal? Your healthcare provider will typically evaluate: Absolute CD4+ and CD8+ counts Total lymphocyte count Other immune markers (e.g., immunoglobulins, inflammatory markers) Your symptoms and medical history Further testing or monitoring may be needed depending on the suspected condition (e.g., HIV viral load, autoimmune screening, or infection panels). Summary The CD4/CD8 ratio (CD3+) is a critical marker of immune system balance. It reflects the relationship between helper and cytotoxic T cells within the overall T cell population. Abnormal ratios may signal immune deficiency, chronic infection, autoimmune disease, or immune system aging. This ratio is best interpreted in the context of absolute T-cell counts and your overall health status.

The marker "CD4/CRTH2" is significant in immunology, specifically in identifying a subset of T helper cells known as Th2 cells. CD4 is a glycoprotein found on the surface of immune cells such as T helper cells, playing a crucial role in the immune response by assisting other cells in the immune system. CRTH2, or chemoattractant receptor-homologous molecule expressed on Th2 cells, is a receptor that selectively marks Th2 cells and is involved in mediating allergic responses and inflammation. Th2 cells are key players in the body's defense against parasites and in the pathogenesis of allergic diseases like asthma and allergic rhinitis. When Th2 cells are activated, they release cytokines such as IL-4, IL-5, and IL-13, which contribute to the recruitment of eosinophils, B-cell activation, and IgE production. Elevated levels of CD4/CRTH2+ T cells are often associated with allergic conditions and can be indicative of an ongoing allergic response or chronic inflammation.

Part of Lyme Testing

Why use the CD57 test? The CD57 test is offered in some clinical laboratories and is being used by some health practitioners to evaluate and follow patients diagnosed with chronic Lyme disease. What is Lyme disease? Lyme disease, the most common vector-borne illness in the United States, is caused by Borrelia burgdorferi and transmitted by the bite of the Ixodes sp. tick (the deer tick). The disease usually begins with erythema migrans, an expanding skin lesion at the site of the tick bite. Within several days or weeks, there is hematogenous dissemination of the spirochetes, and patients may present with dermatologic, neurological, cardiac, and rheumatologic involvement. What is chronic lyme disease? Chronic Lyme disease is a controversial term applied to a broad spectrum of patients, including individuals with Lyme disease and those with post-Lyme disease syndrome (PLDS), as well as patients with no evidence of current or past Borrelia burgdorferi infection. PLDS is defined as the persistence or relapse of nonspecific symptoms (such as fatigue, musculoskeletal pain, and cognitive complaints) in patients who have had Lyme disease and have received an adequate course of antibiotic therapy. It has been reported that people with “chronic Lyme disease” have a decreased number of natural killer cells (NK cells), as defined by the CD57 marker. Although acute infections can be treated with antibiotics, failure to treat may result in a chronic, debilitating illness characterized by musculoskeletal and neurologic symptoms. Chronic Lyme disease may be difficult to treat, but also to diagnose What are white blood cells? White blood cells (=leukocytes) help the body to fight infections and other diseases. The human immune system consists of several different types of white blood cells with one category being called Lymphocytes. Lymphocytes attack antigens (foreign proteins). Lymphocytes consists of 3 subcategories of white blood cells known as B-Cells, T-Cells, and Natural Killer Cells. B-cells – responsible for antibody production T-cells – responsible for killing foreign invaders. natural killer (NK) cells – responsible for killing foreign invaders. Natural killer cells versus T-cells: Natural killer cells are the first line of defense against foreign pathogens and they belong to the innate immune system. They are not specific in their immune response and recognize a wide variety of pathogens. T-cells, on the other side, belong to the adaptive immune system. They are much more focused and highly specialized. What are CD markers? CD stands for cluster designation. CD is a glycoprotein molecule on the cell surface that acts as an identifying marker. Each different marker (or CD) on a cell is named with a number, which signifies the order in which the CD was discovered. Cells that have a certain kind of CD present on their surface are denoted as “+” for that CD type (e.g., a cell with CD57 markers on its surface is “CD57+”. What are CD57 cells? CD57 is a natural killer cell. A below-normal count of CD57+ cells has been associated with chronic Lyme disease. No one knows for sure why CD57+ NK cells are low in Lyme disease patients, but it is important to note that many disease states that are often confused with chronic Lyme (such as MS, systemic lupus, rheumatoid arthritis) are not associated with low CD57+ counts. Borrelia are believed to be capable of reducing the total amount of CD57 natural killer cells in the human body. It is generally believed that the lower the amount of CD57 natural killer cells in the body, the more chronic or progressive Lyme disease is, and the higher the amount, the closer a person is to remission. What are CD8 cells? The CD8 cells are generally referred to as T-cells, not to be confused with natural killer cells. Controversy around using this test: The utility of this test is controversial. Marques et. al. (2009 Clin. Vaccine Immunol. 16:1249-50) reported that there was no difference between the CD57 NK cell counts among patients with Lyme disease and normal controls. There have been instances where high amounts of CD57 natural killers cells have been found in those with chronic Lyme disease, and low amounts of CD57 natural killer cells have been found in those who were believed to be in remission. Possible treatment options: There are various stages of Lyme infection, and treatments differ according to the stage of infection. It’s important to be aware of the various treatment options so that you can help your doctor determine what’s right for you. Treatment options include one or multiple rounds of antibiotics (oral, intravenous, intramuscular, etc). When a patient is diagnosed with Chronic Lyme Disease, doctors work to develop an extended treatment plan. Treating Chronic Lyme can last months, years or even longer. Decisions about the treatment of the patient with chronic Lyme disease need to be individually shaped by the clinician’s experience, the patient’s clinical profile and history of antibiotic responsiveness, and the emerging medical literature. References: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725528/ https://academic.oup.com/cid/article/61/7/1084/289719 https://lymescience.org/wp-content/uploads/2018/11/CD57-unavailable.pdf https://www.sciencedirect.com/science/article/pii/S0399077X18306760 https://cvi.asm.org/content/16/11/1704 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196523/ https://canlyme.com/just-diagnosed/treatment/chronic-lyme-disease/ Disclaimer: The information on healthmatters.io is NOT intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. Reference Range(s): CD57+/CD3- of % Lymphs 1-10 % Lymphocytes CD57+/CD3- of % WBC 1-4 % WBC CD57+/CD3- Cells/uL 20-258 Cells/uL CD57+/CD3-/CD8- of % Lymphs 1-5 % Lymphocytes CD57+/CD3-/CD8- of % WBC 1-3 % WBC CD57+/CD3-/CD8- Cells/uL 20-114 Cells/uL CD57+/CD8- of % Lymphs 1-15 % Lymphocytes CD57+/CD8- of % WBC 1-4 % WBC CD57+/CD8-Cells/uL 20-248 Cells/uL